The Bio Report

563 Episoder

1. Bringing Gender Diversity into Biotech Boardrooms

   Udgivet: 28.9.2017
2. Why the FDA May Need to Rethink Its Approach to Gene and Cell Therapy

   Udgivet: 21.9.2017
3. VBL Targets Brain and other Cancers with Novel Immunotherapy

   Udgivet: 14.9.2017
4. What Will It Take to Transform Healthcare to a System Focused on Prediction and Prevention

   Udgivet: 7.9.2017
5. Can a Direct Pitch to Patients Drive a Home Run for Obesity Drug

   Udgivet: 31.8.2017
6. Why Companies Across Industries Need to Develop a Bio Strategy

   Udgivet: 24.8.2017
7. Economist Argues Maximizing Shareholder Value Hurts Drug Innovation

   Udgivet: 17.8.2017
8. Partnership Drives Development of Antibiotic to Combat Resistant Gonorrhea

   Udgivet: 10.8.2017
9. CIRM-Funded Pipeline of Regenerative Therapies Advances

   Udgivet: 3.8.2017
10. Technology Allows Drugmakers to Tag and Authenticate Individual Pills

    Udgivet: 27.7.2017
11. Harnessing Mosquitoes to Fight the Spread of Infectious Disease

    Udgivet: 20.7.2017
12. Biotech Industry Moves Towards a Patent Cliff

    Udgivet: 13.7.2017
13. PvP Takes a Unique Approach to Treating an Autoimmune Disease

    Udgivet: 6.7.2017
14. Uncertainty Hangs over the Biotech Sector

    Udgivet: 29.6.2017
15. What Others Can Learn from COI’s Approach to Cost-Efficient Drug Development

    Udgivet: 22.6.2017
16. Dyadic Seek to Bring Disruptive Technology to Biomanufacturing

    Udgivet: 15.6.2017
17. Enlisting the Immune System in the Battle Against Alzheimer’s

    Udgivet: 8.6.2017
18. Overcoming the Delivery Challenges of Gene Therapy

    Udgivet: 1.6.2017
19. Brexit Sparks Battle to House the EMA

    Udgivet: 25.5.2017
20. New Safety Concerns Identified After FDA Approval of One in Three Drugs

    Udgivet: 18.5.2017